North America:

  • Tesla CEO Elon Musk rejects merger with xAI despite upcoming shareholder vote on xAI investment.
  • Gilead receives WHO recommendation for injectable lenacapavir for HIV prevention.
  • Kenvue Inc appoints Kirk Perry as interim CEO after Thibaut Mongon's resignation amid strategic review.
  • Autodesk is reportedly no longer pursuing an acquisition of PTC, marking a shift in its M&A intentions.
  • Fastenal beat Q2 estimates with strong demand for safety products, posting $2.08 billion in revenue and 29 cents EPS.
  • Kenvue CEO Thibaut Mongon stepped down amid a strategic review and potential divestitures in its skin-health and beauty division, with Kirk Perry appointed interim CEO.
  • Synopsys received conditional approval from China for its $35 billion acquisition of Ansys, clearing the last regulatory hurdle.
  • Amazon reported a record-breaking Prime Day 2025, with historic sales volumes and high engagement via its AI assistant Rufus.
  • Waters Corp will merge with Becton Dickinson's biosciences and diagnostics business in a $17.5 billion deal, creating a $6.5 billion revenue company by 2025.
  • A Google-backed coalition will invest $1.7 million in early-stage ocean and rock carbon removal startups to accelerate scalable climate solutions.
  • Kraft Heinz is considering spinning off a large part of its food business, including many Kraft products, according to Reuters.
  • Shareholders of Walgreens Boots Alliance have approved the transaction with Sycamore Partners.
  • The CEO of Nvidia will hold a press conference in Beijing on 16 July.
  • Apple has offered at least $150 million per year for the streaming rights to Formula 1, according to Business Insider.

Europe:

  • Bayer gains FDA approval for Finerenone for heart failure and signs a distribution deal with M2i for pheromone gels.
  • GSK submits FDA application to expand RSV vaccine Arexvy for adult use.
  • UniCredit faces EU law concerns over Banco BPM bid conditions, with partial lifting by Italian court.
  • Lifco CEO Per Waldemarson buys shares worth 14.6 million SEK despite Q2 earnings miss and market drop.
  • Sagax reports increased operating result and revised forecast with property acquisitions in France.
  • Partners Group sells Techem for EUR 6.7 billion to enhance digital and energy-efficiency services.
  • Balco Group AB reports decreased Q2 revenue and profit but secures a significant order worth 519 million kronor.
  • Addnode surpasses Q2 financial expectations with earnings of 184 million Swedish kronor.
  • Wizz Air exits Abu Dhabi operations and scales back A321XLR order amid operational challenges.

Rest of the world:

  • Synopsys receives conditional approval from China's market regulator to acquire Ansys.
  • Sun Pharma launches anti-baldness drug Leqselvi in the US post-patent settlement.
  • HCL Tech reports Q1 net profit surpassing estimates and forecasts 3-5% revenue growth for FY26.
  • Abacus Storage King receives revised buyout proposal from Ki Corporation and Public Storage consortium.
  • CSL considers laying off one-third of its R&D workforce.